GlaxoSmithKline

British pharmaceutical company, one of the largest in the world. The headquarters are in Brentford, a suburb of London.

GlaxoSmithKline is the second largest pharmaceutical company in the world (after Pfizer) in terms of turnover. In addition to pharmaceuticals, the company deals with microbiology and body care products. The main production facilities are concentrated in Great Britain, Spain, Ireland, USA and Singapore. The main sales are provided by drugs in therapeutic areas: respiratory diseases, oncology, HIV / AIDS, diabetes, mental disorders, prevention of infectious diseases (vaccines for different age groups), drugs sold in pharmacies on the recommendation of a doctor (Augmentin, Bekotid, Zinacef, Zinnat, Fortum, Energin, etc.) and symptomatic drugs sold in pharmacies without a prescription (Panadol, Coldrex, Solpadein, etc.).

GSK is doing a lot of research work; the main research centers of the company are located in Greenford (a suburb of London), Harlow (UK), as well as in the states of North Carolina and Pennsylvania (USA).

British headquarters of the company

The total number of personnel is about 100 thousand people (2008). Revenue in 2008 was £ 24.35 billion. Net income for this period was £ 7.4 billion.

As of February 2018, GSK sold its products in over 160 countries. Total global sales in 2017 amounted to £ 30.186 billion. Sales of innovative products (launched in the last three years) accounted for about 13% of total sales.